Zobrazeno 1 - 10 of 287 pro vyhledávání: '"Sc, Gilbert"'
1
Chimpanzee adenovirus vaccine provides multispecies protection against Rift valley fever
Autor: Gm, Warimwe, Gesharisha J, Bv, Carr, Otieno S, Otingah K, Wright D, Charleston B, Okoth E, Lg, Elena, Lorenzo G, Ayman el-B, Nk, Alharbi, Ma, Al-Dubaib, Brun A, Sc, Gilbert, Nene V, Adrian Hill
Publikováno v: Repositorio de Resultados de Investigación del INIA
INIA: Repositorio de Resultados de Investigación del INIA
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria INIA
Scientific Reports
Europe PubMed Central
Rift Valley Fever virus (RVFV) causes recurrent outbreaks of acute life-threatening human and livestock illness in Africa and the Arabian Peninsula. No licensed vaccines are currently available for humans and those widely used in livestock have major
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d1bd60a5b3cf71d5f2600869ec69594b
http://hdl.handle.net/10261/293286
Zobrazit plný text záznamu
5
Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid
Autor: Lambe T, Rampling T, Samuel D, Bowyer G, Kj, Ewer, Venkatraman N, Edmans M, Dicks S, Adrian Hill, Rs, Tedder, Sc, Gilbert
Publikováno v: Europe PubMed Central
Blood sampling to assess production of antigen-specific antibodies after immunization is commonly performed, but it presents logistical difficulties for trials carried out during an infectious disease outbreak. In this study, we show that antibodies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f0be13327ecea6afdbf6a3fdb53350cf
http://europepmc.org/abstract/med/27004234
Zobrazit plný text záznamu
6
Akademický článek
Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig.
Autor: Vatzia E; The Pirbright Institute, Pirbright, UK., Paudyal B; The Pirbright Institute, Pirbright, UK., Dema B; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Carr BV; The Pirbright Institute, Pirbright, UK., Sedaghat-Rostami E; The Pirbright Institute, Pirbright, UK., Gubbins S; The Pirbright Institute, Pirbright, UK., Sharma B; The Pirbright Institute, Pirbright, UK., Moorhouse E; The Pirbright Institute, Pirbright, UK., Morris S; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ulaszewska M; Nuffield Department of Medicine, University of Oxford, Oxford, UK., MacLoughlin R; Aerogen Ltd., Galway, Ireland., Salguero FJ; United Kingdom Health Security Agency, UKHSA-Porton Down, Salisbury, UK., Gilbert SC; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tchilian E; The Pirbright Institute, Pirbright, UK. elma.tchilian@pirbright.ac.uk.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Oct 13; Vol. 9 (1), pp. 188. Date of Electronic Publication: 2024 Oct 13.
Zobrazit plný text záznamu
7
Akademický článek
Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine.
Autor: Wee EG; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Kempster S; Science and Research-Diagnostics, Medicines and Healthcare products Regulatory Agency, Potters Bar EN6 3QG, UK., Ferguson D; Science and Research-Diagnostics, Medicines and Healthcare products Regulatory Agency, Potters Bar EN6 3QG, UK., Hall J; Science and Research-Diagnostics, Medicines and Healthcare products Regulatory Agency, Potters Bar EN6 3QG, UK., Ham C; Science and Research-Diagnostics, Medicines and Healthcare products Regulatory Agency, Potters Bar EN6 3QG, UK., Morris S; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Crook A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Gilbert SC; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK., Korber B; New Mexico Consortium, Los Alamos, NM 87544, USA., Almond N; Science and Research-Diagnostics, Medicines and Healthcare products Regulatory Agency, Potters Bar EN6 3QG, UK., Hanke T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-0811, Japan.
Publikováno v: Vaccines [Vaccines (Basel)] 2024 Aug 26; Vol. 12 (9). Date of Electronic Publication: 2024 Aug 26.
Zobrazit plný text záznamu
8
Akademický článek
Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.
Autor: Drury RE; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Camara S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Sanders K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Felle S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Emary K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Phillips D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., Ferreira DM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Klenerman P; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert SC; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.; Chinese Academy of Medical Science (CAMS) Oxford Institute, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK., O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. daniel.oconnor@paediatrics.ox.ac.uk.; NIHR Oxford Biomedical Research Centre, Oxford, UK. daniel.oconnor@paediatrics.ox.ac.uk.
Publikováno v: Nature communications [Nat Commun] 2024 Apr 22; Vol. 15 (1), pp. 3402. Date of Electronic Publication: 2024 Apr 22.
Zobrazit plný text záznamu
9
Akademický článek
Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters.
Autor: Port JR; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Yinda CK; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Riopelle JC; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Weishampel ZA; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Saturday TA; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Avanzato VA; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Schulz JE; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Holbrook MG; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Barbian K; Genomics Research Section, Research Technologies Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Perry-Gottschalk R; Rocky Mountain Visual and Medical Arts Unit, Research Technologies Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Haddock E; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Martens C; Genomics Research Section, Research Technologies Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Shaia CI; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science Oxford Institute; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Gilbert SC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., van Doremalen N; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA., Munster VJ; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. vincent.munster@nih.gov.
Publikováno v: Nature communications [Nat Commun] 2023 Oct 18; Vol. 14 (1), pp. 6592. Date of Electronic Publication: 2023 Oct 18.
Zobrazit plný text záznamu
10
Akademický článek
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial.
Autor: Jenkin D; The Jenner Institute, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, University of Oxford, Oxford, UK; Department of Paediatrics, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, University of Oxford, Oxford, UK., Platt A; The Jenner Institute, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, University of Oxford, Oxford, UK., Tran N; The Jenner Institute, University of Oxford, Oxford, UK., Boyd A; The Jenner Institute, University of Oxford, Oxford, UK., Turner C; The Jenner Institute, University of Oxford, Oxford, UK., Gitonga JN; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Ewer KJ; The Jenner Institute, University of Oxford, Oxford, UK., Bowden TA; Wellcome Centre for Human Genetics, Division of Structural Biology, University of Oxford, Oxford, UK., Gilbert SC; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK; Pandemic Sciences Institute, University of Oxford, Oxford, UK., Charleston B; The Pirbright Institute, Pirbright, UK., Kaleebu P; Medical Research Council-Uganda Virus Research Institute and The London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda., Hill AVS; The Jenner Institute, University of Oxford, Oxford, UK., Warimwe GM; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya. Electronic address: gwarimwe@kemri-wellcome.org.
Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 956-964. Date of Electronic Publication: 2023 Apr 13.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje